Latest Headlines
-
ROSS DPM-150 Double Planetary Mixer Designed For High-Volume Production In Hazardous Locations
8/28/2025
A well-proven tool for robust mixing of high-viscosity materials, the ROSS Double Planetary Mixer delivers exceptional performance through its unique agitation system and adaptability, while meeting explosion-proof requirements. The Model DPM-150 is a heavy-duty mixer that can process formulations ranging from 20 to 150 gallons, with viscosities exceeding 6 million centipoise. It is one of several ROSS production models serving thousands of pharmaceutical, aerospace, adhesives, sealants, composites, and specialty chemical manufacturing plants around the world.
-
OPTEL Acquires Vanguard Robotics To Accelerate Innovation In Pharma Automation
8/28/2025
OPTEL Group, a global leader in pharmaceutical traceability and supply chain solutions, proudly announces the acquisition of Vanguard Robotics, an expert in end-of-line collaborative robot (cobot) automation. This strategic move reinforces OPTEL’s commitment to innovation and positions the company at the forefront of pharmaceutical automation.
-
Federal Equipment Company And Proxio Group Announce Equipment Auction With Capsule Fillers, Fluid Bed Dryers, Agilent HPLC Systems, Lyophilizers, Roller Compactors, Etc.
8/27/2025
Federal Equipment Company, in conjunction with Proxio Group, is hosting a global online auction featuring capsule fillers, fluid bed dryers, Agilent HPLC systems, various lab pumps, lyophilizers, Vector roller compactors, M&O Perry fillers & more for your every need.
-
RABS Vs Pharmaceutical Isolators: Which Technology Is Best For An Efficient Contamination Control Strategy?
8/26/2025
The publication of the new GMP Annex 1 has redefined the standards for managing aseptic processes, with the primary objective of minimizing contamination risks. This revision reflects the evolution of sterile processes and products, which are becoming increasingly diverse and complex, and the need for pharmaceutical companies to comply with stricter regulatory requirements.
-
Genentech And Roche Breaks Ground On New Drug Manufacturing Facility In Holly Springs NC
8/26/2025
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today broke ground on its newest U.S. manufacturing site in Holly Springs, North Carolina. This significant development marks the establishment of Genentech’s first manufacturing facility on the East Coast.
- CDMO Piramal Pharma Solutions, NewAmsterdam Pharma Partner To Expand Oral Solid Dosage Production At Sellersville, PA Manufacturing Site 8/22/2025
-
Europharma Installs MES Software From Korber To Replace Manual Processes
8/22/2025
Eurofarma Laboratórios has successfully transitioned all of its manufacturing operations at the main production facility in Itapevi, São Paulo to Körber’s PAS-X Manufacturing Execution System – becoming the first national company in Brazil to do so. The implementation paves the way to operational excellence, enabling real-time data access, full traceability, and enhanced regulatory compliance.
-
BioMed X Joins Forces With Novo Nordisk For Oral Peptide Drug Delivery
8/20/2025
BioMed X, an independent biomedical research institute based in Heidelberg, Germany, announced today the launch of a new collaboration with Novo Nordisk, a leading global healthcare company headquartered in Denmark. This partnership aims to address one of the most critical challenges in modern drug development: the efficient oral delivery of therapeutic peptides. A research team will be formed to work on this challenge with support from BioMed X and Novo Nordisk.
-
Particle Measuring Systems Opens New Manufacturing & Innovation Hub To Drive Future Growth In Colorado
8/19/2025
Particle Measuring Systems is proud to announce the opening of its new state-of-the-art Manufacturing & Innovation Hub, marking a major milestone in the company’s evolution and long-term growth and investment strategy. This purpose-built facility is designed to support innovation, enhance customer engagement and service delivery, and expand manufacturing capabilities—solidifying our leadership in advancing contamination-free manufacturing and sterility assurance.
-
Upperton Pharma Solutions Awarded VaxHub Sustainable Grant To Advance Oral Vaccine Delivery In Partnership With The University Of Oxford's Pandemic Sciences Institute
8/18/2025
Upperton Pharma Solutions, a leading UK-based CDMO, has been awarded a grant as part of the first VaxHub Sustainable Platform Funding Call, in collaboration with the University of Oxford. The funding supports the development of an oral formulation for Adenovirus-vectored vaccines.